Shares of Sernova Corp. (TSE:SVA – Get Free Report) hit a new 52-week low during mid-day trading on Monday . The company traded as low as C$0.13 and last traded at C$0.14, with a volume of 95621 shares trading hands. The stock had previously closed at C$0.13.
Sernova Trading Up 4.0%
The company has a 50-day moving average price of C$0.14 and a two-hundred day moving average price of C$0.16. The stock has a market cap of C$43.77 million, a P/E ratio of -2.60 and a beta of 0.96. The company has a current ratio of 0.32, a quick ratio of 18.11 and a debt-to-equity ratio of -4.40.
Sernova Company Profile
Sernova Biotherapeutics is a clinical-stage company developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem cells to create a bio-hybrid organ. A bio-hybrid organ refers to a medical device designed to be implanted into the human body, where it integrates with existing living tissue to replicate or enhance the function of a natural organ, essentially aiming to restore normal organ function by combining living cells with non-living materials to mimic the properties of the original organ and seamlessly interact with surrounding tissues.
Further Reading
- Five stocks we like better than Sernova
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- This stock gets a 94 out of 100
- The $100 Trillion AI Story No One Is Telling You
- 3 Overlooked Deductions to Help Potentially Minimize Capital Gains Tax
Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.
